VOSO, MARIA TERESA
VOSO, MARIA TERESA
Dipartimento di Biomedicina e Prevenzione
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature
2011-01-01 Greco, M; Criscuolo, M; Fianchi, L; Fabiani, E; Pagano, L; Voso, Mt
[Myeloproliferative disorders due to the use of gasoline as a solvent: report of three cases]
2005-01-01 Bernardini, P; Giannandrea, F; Voso, Mt; Sica, S
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry
2017-01-01 Mayer, F; Faglioni, L; Agabiti, N; Fenu, S; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, M; Tatarelli, C; Breccia, M; Cimino, G; Fianchi, L; Criscuolo, M; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, A; Tafuri, A; Trapè, G; Andriani, A; DE FABRITIIS, P; Voso, Mt; Davoli, M; Zini, G
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML
2022-01-01 Zeidan, Am; Boss, Iw; Beach, Cl; Copeland, Wb; Thompson, Eg; Fox, Ba; Hasle, Ve; Hellmann, A; Taussig, D; Tormo, M; Voso, Mt; Cavenagh, J; O'Connor, T; Previtali, A; Rose, S; Silverman, Lr
A randomized phase 2 trial of azacitidine ± durvalumab as first-line therapy for higher-risk myelodysplastic syndromes
2022-01-01 Zeidan, Am; Boss, Iw; Beach, Cl; Copeland, Wb; Thompson, Eg; Fox, Ba; Hasle, Ve; Ogasawara, K; Cavenagh, J; Silverman, Lr; Voso, Mt; Hellmann, A; Tormo, M; O'Connor, T; Previtali, A; Rose, S; Garcia-Manero, G
A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib
2021-01-01 Perrone, S; Ortu La Barbera, E; Viola, F; Cipollone, E; Scerpa, Mc; Siniscalchi, R; Ottone, T; Voso, Mt; Cimino, G
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
2023-02-01 Maggioni, G; Bersanelli, M; Travaglino, E; Alfonso Piérola, A; Kasprzak, A; Sangerman Montserrat, A; Sauta, E; Sala, C; Matteuzzi, T; Meggendorfer, M; Gnocchi, M; Zhao, L; Tentori, Ca; Nachtkamp, K; Dall'Olio, D; Mosca, E; Ubezio, M; Campagna, A; Russo, A; Rivoli, G; Bernardi, M; Borin, L; Voso, Mt; Riva, M; Oliva, E; Zampini, M; Riva, E; Saba, E; D'Amico, S; Lanino, L; Tinterri, B; Re, F; Bicchieri, M; Giordano, L; Angelotti, G; Morandini, P; Kubasch, As; Passamonti, F; Rambaldi, A; Savevski, V; Santoro, A; van de Loosdrecht, Aa; Brogi, A; Santini, V; Kordasti, S; Sanz, G; Sole, F; Gattermann, N; Kern, W; Platzbecker, U; Ades, L; Fenaux, P; Haferlach, T; Castellani, G; Germing, U; Diez-Campelo, M; Della Porta, Mg
Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes
2004-01-15 Voso, Mt; Scardocci, A; Guidi, F; Zini, G; Di Mario, A; Pagano, L; Hohaus, S; Leone, G
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration
2020-03-16 Banella, C; Ginevrino, M; Catalano, G; Fabiani, E; Falconi, G; Divona, M; Curzi, P; Panetta, P; Voso, Mt; Noguera, Ni
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
2015-08-01 Caocci, G; Voso, Mt; Angelucci, E; Stauder, R; Cottone, F; Abel, G; Nguyen, K; Platzbecker, U; Beyne Rauzy, O; Gaidano, G; Invernizzi, R; Molica, S; Criscuolo, M; Breccia, M; Lübbert, M; Sanpaolo, G; Buccisano, F; Ricco, A; Palumbo, G; Niscola, P; Zhang, H; Fenu, S; La Nasa, G; Mandelli, F; Efficace, F
Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre
2003-08-01 Di Febo, A; Mele, L; Fianchi, L; Scardocci, A; Voso, Mt; Falcucci, P; Trapè, G; Leone, G; Pagano, L
Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient
2023-05-17 Niscola, P; Mazzone, C; Fratoni, S; Ardu, Nr; Cesini, L; Giovannini, M; Ottone, T; Anemona, L; Voso, Mt; de Fabritiis, P
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols
2021-01-01 Rosati, S; Gurnari, C; Breccia, M; Carmosino, I; Scalzulli, E; Montefusco, E; Perrone, S; Annibali, O; Martini, V; Trapè, G; Colafigli, G; Trawinska, M; Minotti, C; Cimino, G; Tafuri, A; Avvisati, G; Martelli, M; Voso, Mt; Latagliata, R
Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient
2020-10-01 Perrone, S; Ortu La Barbera, E; Ottone, T; Capriata, M; Passucci, M; Filippi, L; Bagni, O; Voso, Mt; Cimino, G
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
2021-01-11 Gurnari, C; Voso, Mt; Girardi, K; Mastronuzzi, A; Strocchio, L
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies
2019-10-01 Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt
Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer
1999-01-01 Hohaus, S; Martin, S; Schneeweiss, A; Voso, Mt; Schlenk, R; Wallwiener, D; Bastert, G; Haas, R
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial
2021-01-01 Mannelli, F; Gianfaldoni, G; Guglielmelli, P; Buccisano, F; Caporale, R; Chiarini, M; Rossi, G; Venditti, A; Fazi, P; Crea, E; Piciocchi, A; Voso, Mt; Vignetti, M; Amadori, S; Vannucchi, Am
AML: making residual disease more measurable
2022-01-01 Voso, Mt; Buccisano, F
An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome
2015-01-01 Martini, M; Capodimonti, S; Iachininoto, M; Cocomazzi, A; Nuzzolo, E; Voso, Mt; Teofili, L; Larocca, L
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2011 | 5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature | Greco, M; Criscuolo, M; Fianchi, L; Fabiani, E; Pagano, L; Voso, Mt | Articolo su rivista | |
| 1-gen-2005 | [Myeloproliferative disorders due to the use of gasoline as a solvent: report of three cases] | Bernardini, P; Giannandrea, F; Voso, Mt; Sica, S | Articolo su rivista | |
| 1-gen-2017 | A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry | Mayer, F; Faglioni, L; Agabiti, N; Fenu, S; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, M; Tatarelli, C; Breccia, M; Cimino, G; Fianchi, L; Criscuolo, M; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, A; Tafuri, A; Trapè, G; Andriani, A; DE FABRITIIS, P; Voso, Mt; Davoli, M; Zini, G | Articolo su rivista | |
| 1-gen-2022 | A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML | Zeidan, Am; Boss, Iw; Beach, Cl; Copeland, Wb; Thompson, Eg; Fox, Ba; Hasle, Ve; Hellmann, A; Taussig, D; Tormo, M; Voso, Mt; Cavenagh, J; O'Connor, T; Previtali, A; Rose, S; Silverman, Lr | Articolo su rivista | |
| 1-gen-2022 | A randomized phase 2 trial of azacitidine ± durvalumab as first-line therapy for higher-risk myelodysplastic syndromes | Zeidan, Am; Boss, Iw; Beach, Cl; Copeland, Wb; Thompson, Eg; Fox, Ba; Hasle, Ve; Ogasawara, K; Cavenagh, J; Silverman, Lr; Voso, Mt; Hellmann, A; Tormo, M; O'Connor, T; Previtali, A; Rose, S; Garcia-Manero, G | Articolo su rivista | |
| 1-gen-2021 | A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib | Perrone, S; Ortu La Barbera, E; Viola, F; Cipollone, E; Scerpa, Mc; Siniscalchi, R; Ottone, T; Voso, Mt; Cimino, G | Articolo su rivista | |
| 1-feb-2023 | A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study | Maggioni, G; Bersanelli, M; Travaglino, E; Alfonso Piérola, A; Kasprzak, A; Sangerman Montserrat, A; Sauta, E; Sala, C; Matteuzzi, T; Meggendorfer, M; Gnocchi, M; Zhao, L; Tentori, Ca; Nachtkamp, K; Dall'Olio, D; Mosca, E; Ubezio, M; Campagna, A; Russo, A; Rivoli, G; Bernardi, M; Borin, L; Voso, Mt; Riva, M; Oliva, E; Zampini, M; Riva, E; Saba, E; D'Amico, S; Lanino, L; Tinterri, B; Re, F; Bicchieri, M; Giordano, L; Angelotti, G; Morandini, P; Kubasch, As; Passamonti, F; Rambaldi, A; Savevski, V; Santoro, A; van de Loosdrecht, Aa; Brogi, A; Santini, V; Kordasti, S; Sanz, G; Sole, F; Gattermann, N; Kern, W; Platzbecker, U; Ades, L; Fenaux, P; Haferlach, T; Castellani, G; Germing, U; Diez-Campelo, M; Della Porta, Mg | Articolo su rivista | |
| 15-gen-2004 | Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes | Voso, Mt; Scardocci, A; Guidi, F; Zini, G; Di Mario, A; Pagano, L; Hohaus, S; Leone, G | Articolo su rivista | |
| 16-mar-2020 | Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration | Banella, C; Ginevrino, M; Catalano, G; Fabiani, E; Falconi, G; Divona, M; Curzi, P; Panetta, P; Voso, Mt; Noguera, Ni | Articolo su rivista | |
| 1-ago-2015 | Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes | Caocci, G; Voso, Mt; Angelucci, E; Stauder, R; Cottone, F; Abel, G; Nguyen, K; Platzbecker, U; Beyne Rauzy, O; Gaidano, G; Invernizzi, R; Molica, S; Criscuolo, M; Breccia, M; Lübbert, M; Sanpaolo, G; Buccisano, F; Ricco, A; Palumbo, G; Niscola, P; Zhang, H; Fenu, S; La Nasa, G; Mandelli, F; Efficace, F | Articolo su rivista | |
| 1-ago-2003 | Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre | Di Febo, A; Mele, L; Fianchi, L; Scardocci, A; Voso, Mt; Falcucci, P; Trapè, G; Leone, G; Pagano, L | Articolo su rivista | |
| 17-mag-2023 | Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient | Niscola, P; Mazzone, C; Fratoni, S; Ardu, Nr; Cesini, L; Giovannini, M; Ottone, T; Anemona, L; Voso, Mt; de Fabritiis, P | Articolo su rivista | |
| 1-gen-2021 | Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols | Rosati, S; Gurnari, C; Breccia, M; Carmosino, I; Scalzulli, E; Montefusco, E; Perrone, S; Annibali, O; Martini, V; Trapè, G; Colafigli, G; Trawinska, M; Minotti, C; Cimino, G; Tafuri, A; Avvisati, G; Martelli, M; Voso, Mt; Latagliata, R | Articolo su rivista | |
| 1-ott-2020 | Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient | Perrone, S; Ortu La Barbera, E; Ottone, T; Capriata, M; Passucci, M; Filippi, L; Bagni, O; Voso, Mt; Cimino, G | Articolo su rivista | |
| 11-gen-2021 | Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy | Gurnari, C; Voso, Mt; Girardi, K; Mastronuzzi, A; Strocchio, L | Articolo su rivista | |
| 1-ott-2019 | Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies | Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt | Articolo su rivista | |
| 1-gen-1999 | Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer | Hohaus, S; Martin, S; Schneeweiss, A; Voso, Mt; Schlenk, R; Wallwiener, D; Bastert, G; Haas, R | Articolo su rivista | |
| 1-gen-2021 | AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial | Mannelli, F; Gianfaldoni, G; Guglielmelli, P; Buccisano, F; Caporale, R; Chiarini, M; Rossi, G; Venditti, A; Fazi, P; Crea, E; Piciocchi, A; Voso, Mt; Vignetti, M; Amadori, S; Vannucchi, Am | Articolo su rivista | |
| 1-gen-2022 | AML: making residual disease more measurable | Voso, Mt; Buccisano, F | Articolo su rivista | |
| 1-gen-2015 | An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome | Martini, M; Capodimonti, S; Iachininoto, M; Cocomazzi, A; Nuzzolo, E; Voso, Mt; Teofili, L; Larocca, L | Articolo su rivista |